Link to this page
National Cancer Institute Thesaurus
Preferred Name | Pegylated Interferon Alfa | |
Synonyms |
Pegylated Interferon Alfa PEG-interferon alfa PEG-IFN-a |
|
Definitions |
A covalent conjugate of recombinant interferon alpha and polyethylene glycol (PEG), used as an antiviral and antineoplastic agent. The biological activity of this agent is derived from its interferon alpha protein moiety. Interferons alfa bind to specific cell-surface receptors, leading to the transcription and translation of genes whose protein products mediate antiviral, antiproliferative, anticancer, and immune-modulating effects. The PEG moiety lowers the clearance of interferon alpha, thereby extending the duration of its therapeutic effects, but may also reduce interferon-mediated stimulation of an immune response. (NCI04) |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2491 |
|
Accepted_Therapeutic_Use_For |
Hepatitis C.
|
|
code |
C2491
|
|
Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157712 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977 |
|
Contributing_Source |
CTRP GDC
|
|
DEFINITION |
A covalent conjugate of recombinant interferon alpha and polyethylene glycol (PEG), used as an antiviral and antineoplastic agent. The biological activity of this agent is derived from its interferon alpha protein moiety. Interferons alfa bind to specific cell-surface receptors, leading to the transcription and translation of genes whose protein products mediate antiviral, antiproliferative, anticancer, and immune-modulating effects. The PEG moiety lowers the clearance of interferon alpha, thereby extending the duration of its therapeutic effects, but may also reduce interferon-mediated stimulation of an immune response. (NCI04)
|
|
Display_Name |
Pegylated Interferon Alfa
|
|
FULL_SYN |
Pegylated Interferon Alfa PEG-interferon alfa PEG-IFN-a
|
|
Is_Value_For_GDC_Property | ||
label |
Pegylated Interferon Alfa
|
|
Legacy Concept Name |
Pegylated_Interferon_Alfa
|
|
Maps_To |
Pegylated Interferon Alfa
|
|
NCI_Drug_Dictionary_ID |
43151
|
|
PDQ_Closed_Trial_Search_ID |
43151
|
|
PDQ_Open_Trial_Search_ID |
43151
|
|
Preferred_Name |
Pegylated Interferon Alfa
|
|
prefixIRI |
Thesaurus:C2491
|
|
Semantic_Type |
Organic Chemical Pharmacologic Substance
|
|
UMLS_CUI |
C0907160
|
|
subClassOf |
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Mapping To | Ontology | Source |
---|---|---|
http://purl.obolibrary.org/obo/NCIT_C2491 | BERO | LOOM |
http://sbmi.uth.tmc.edu/ontology/ochv#48970 | OCHV | LOOM |
http://sbmi.uth.tmc.edu/ontology/ochv#C0796333 | OCHV | LOOM |
http://purl.bioontology.org/ontology/PDQ/CDR0000043151 | PDQ | LOOM |